Jorge Plutzky, cardiologist perspective on RA at #ACR21 ⭐️CANTOS: Canakinumab for MACE shows ⬇️ inflammation, no change in LDL. Improvement in MACE events ▶️Plutzky: "Proof of concept study" @Rheumnow https://t.co/Xi9ZHxMtmu